Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Friedrich Foerster

Showing results (21-30 of 60) with videos related to

Pageof 6
Sort By:
Journal of Clinical Medicine|June 2, 2021
Survival Prediction in Intrahepatic Cholangiocarcinoma: A Proof of Concept Study Using Artificial Intelligence for Risk AssessmentLukas Müller, Aline Mähringer-Kunz, Simon Johannes Gairing, et al.
Nanomedicine (London, England)|September 16, 2016
Dextran-based therapeutic nanoparticles for hepatic drug deliveryFriedrich Foerster, Denise Bamberger, Jonathan Schupp, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 4, 2025
Vascular resection and reconstruction in surgery for advanced intrahepatic cholangiocarcinoma - single center experience with 59 vascular resectionsHauke Lang, Lisa-Katharina Gröger, Beate K Straub, et al.
Cancer Discovery|June 19, 2013
ZNF365 promotes stability of fragile sites and telomeresYuqing Zhang, Sandra J Shin, Debra Liu, et al.
BMC Cancer|January 13, 2019
Safety and efficacy of afatinib as add-on to standard therapy of gemcitabine/cisplatin in chemotherapy-naive patients with advanced biliary tract cancer: an open-label, phase I trial with an extensive biomarker programMarkus Moehler, Annett Maderer, Anne Ehrlich, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 23, 2019
Biology and significance of alpha-fetoprotein in hepatocellular carcinomaPeter R Galle, Friedrich Foerster, Masatoshi Kudo, et al.
Scientific Reports|July 17, 2024
Amount of ascites impacts survival in patients with hepatocellular carcinoma undergoing transarterial chemoembolization advocating for volumetric assessmentLukas Müller, Daniel Bender, Simon J Gairing, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|September 24, 2022
The prognostic role of early tumor shrinkage in patients with hepatocellular carcinoma undergoing immunotherapyLukas Müller, Simon Johannes Gairing, Roman Kloeckner, et al.
Journal of Clinical Medicine|June 2, 2021
Influence of Lymphangio (L), Vascular (V), and Perineural (Pn) Invasion on Recurrence and Survival of Resected Intrahepatic CholangiocarcinomaFabian Bartsch, Lisa-Katharina Heuft, Janine Baumgart, et al.
Frontiers in Surgery|June 1, 2026
A novel endpoint for liver surgery predicts surgery-related mortality: external validation in a surgical cohort with intrahepatic cholangiocarcinomaConstantin Scholz, Evangelos Tagkalos, Franziska Renger, et al.
Pageof 6

Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
Journal of Clinical Medicine|June 2, 2021
Survival Prediction in Intrahepatic Cholangiocarcinoma: A Proof of Concept Study Using Artificial Intelligence for Risk AssessmentLukas Müller, Aline Mähringer-Kunz, Simon Johannes Gairing, et al.
Nanomedicine (London, England)|September 16, 2016
Dextran-based therapeutic nanoparticles for hepatic drug deliveryFriedrich Foerster, Denise Bamberger, Jonathan Schupp, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 4, 2025
Vascular resection and reconstruction in surgery for advanced intrahepatic cholangiocarcinoma - single center experience with 59 vascular resectionsHauke Lang, Lisa-Katharina Gröger, Beate K Straub, et al.
Cancer Discovery|June 19, 2013
ZNF365 promotes stability of fragile sites and telomeresYuqing Zhang, Sandra J Shin, Debra Liu, et al.
BMC Cancer|January 13, 2019
Safety and efficacy of afatinib as add-on to standard therapy of gemcitabine/cisplatin in chemotherapy-naive patients with advanced biliary tract cancer: an open-label, phase I trial with an extensive biomarker programMarkus Moehler, Annett Maderer, Anne Ehrlich, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 23, 2019
Biology and significance of alpha-fetoprotein in hepatocellular carcinomaPeter R Galle, Friedrich Foerster, Masatoshi Kudo, et al.
Scientific Reports|July 17, 2024
Amount of ascites impacts survival in patients with hepatocellular carcinoma undergoing transarterial chemoembolization advocating for volumetric assessmentLukas Müller, Daniel Bender, Simon J Gairing, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|September 24, 2022
The prognostic role of early tumor shrinkage in patients with hepatocellular carcinoma undergoing immunotherapyLukas Müller, Simon Johannes Gairing, Roman Kloeckner, et al.
Journal of Clinical Medicine|June 2, 2021
Influence of Lymphangio (L), Vascular (V), and Perineural (Pn) Invasion on Recurrence and Survival of Resected Intrahepatic CholangiocarcinomaFabian Bartsch, Lisa-Katharina Heuft, Janine Baumgart, et al.
Frontiers in Surgery|June 1, 2026
A novel endpoint for liver surgery predicts surgery-related mortality: external validation in a surgical cohort with intrahepatic cholangiocarcinomaConstantin Scholz, Evangelos Tagkalos, Franziska Renger, et al.
Pageof 6